WHYY1h
5 years since the pandemic started, long COVID patients are still hoping for a cure
They're pushing for more funding to find effective treatments. Researchers are finally starting to make headway but have a ...
Gilead Presents New HIV Treatment And Cure Research Data
Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...
Daily Maverick on MSN4h
US funding cuts imperil African search for HIV vaccine
A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in ...
The Standard5hOpinion
Funding cuts threaten search for better TB and HIV drugs
HIV is not like TB. While TB treatment takes six long months, this is a curable disease. HIV, on the other hand, cannot be ...
Immune response may be harnessed to control HIV, primary trial results suggest
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
BioWorld1d
At CROI, HIV cure trials raise hopes for broader applicability
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full day of the conference, reports from the ...
Healio1d
Two more people potentially cured of HIV
Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
Fierce Biotech1d
Immunocore T-cell engager clears safety hurdle, reduces HIV reservoir in some patients
Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...